BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 4:06:00 PM | Browse: 1027 | Download: 839
Publication Name World Journal of Gastroenterology
Manuscript ID 8615
Country Japan
Received
2013-12-31 11:53
Peer-Review Started
2013-12-31 19:34
To Make the First Decision
2014-01-15 17:23
Return for Revision
2014-01-21 10:48
Revised
2014-02-25 13:20
Second Decision
2014-05-05 09:30
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-05 09:59
Articles in Press
2014-05-23 10:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-05-20 02:06
Typeset the Manuscript
2014-07-10 15:37
Publish the Manuscript Online
2014-07-26 13:36
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Clinical Trials Study
Article Title Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer
Manuscript Source Invited Manuscript
All Author List Atsushi Sofuni, Fuminori Moriyasu, Takatomo Sano, Fumihide Itokawa, Takayoshi Tsuchiya, Toshio Kurihara, Kentaro Ishii, Syujiro Tsuji, Nobuhito Ikeuchi, Reina Tanaka, Junko Umeda, Ryosuke Tonozuka, Mitsuyoshi Honjo, Shuntaro Mukai, Mitsuru Fujita and Takao Itoi
Funding Agency and Grant Number
Funding Agency Grant Number
cancer research project group of Tokyo Medical University
Corresponding Author Atsushi Sofuni, MD, PhD, Department of Gastroenterology and Hepatology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan. a-sofuni@amy.hi-ho.ne.jp
Key Words High-intensity focused ultrasound; Pancreatic cancer; Safety trial; Tumor ablation; Ultrasonography
Core Tip The results of chemotherapy and chemoradiotherapy for unresectable pancreatic cancer (PC) have not been satisfactory. Therefore, new advances in therapy are expected. High-intensity focused ultrasound (HIFU), which uses focused ultrasound energy for therapeutic methods such as tissue ablation from an external body, is a new ultrasound technology. HIFU therapy is a new technology therapy for PC. The HIFU device used in this study was the FEP-BY02 (Yuande Bio-Medical Engineering, Beijing, China), which is designed to reduce adverse events. According to the current safety trial, HIFU therapy is non-invasive and promising for clinical effectiveness. HIFU therapy has the potential to be a new method of combination therapy for PC.
Publish Date 2014-07-26 13:36
Citation Sofuni A, Moriyasu F, Sano T, Itokawa F, Tsuchiya T, Kurihara T, Ishii K, Tsuji S, Ikeuchi N, Tanaka R, Umeda J, Tonozuka R, Honjo M, Mukai S, Fujita M, Itoi T. Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer. World J Gastroenterol 2014; 20(28): 9570-9577
URL http://www.wjgnet.com/1007-9327/full/v20/i28/9570.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i28.9570
Full Article (PDF) WJG-20-9570.pdf
Full Article (Word) WJG-20-9570.doc
Manuscript File 8615-Review.doc
Answering Reviewers 8615-Answering reviewers.pdf
Copyright License Agreement 8615-Copyright assignment.PDF
Non-Native Speakers of English Editing Certificate 8615-Language certificate.pdf
Peer-review Report 8615-Peer review(s).pdf
Scientific Editor Work List 8615-Scientific editor work list.doc